We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

148 hedge funds and large institutions have $1.32B invested in Acorda Therapeutics in 2013 Q2 according to their latest regulatory filings, with 148 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

475% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $2.56M

Holders
148
Holders Change
+148
Holders Change %
–
% of All Funds
4.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
148
Increased
–
Reduced
–
Closed
–
Calls
$14.7M
Puts
$2.56M
Net Calls
+$12.2M
Net Calls Change
+$12.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$197M +$205M +49,878 New
UBS AM
2
UBS AM
Illinois
$81.3M +$84.6M +20,537 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$80.9M +$84.2M +20,443 New
BFA
4
BlackRock Fund Advisors
California
$76.4M +$79.5M +19,301 New
EAM
5
Eagle Asset Management
Florida
$67.2M +$69.9M +16,979 New
OIM
6
Oracle Investment Management
Connecticut
$65.9M +$68.5M +16,637 New
AG
7
Artal Group
Luxembourg
$49.5M +$51.5M +12,500 New
Invesco
8
Invesco
Georgia
$48.2M +$50.2M +12,184 New
State Street
9
State Street
Massachusetts
$46.7M +$48.5M +11,786 New
Wellington Management Group
10
Wellington Management Group
Massachusetts
$41.2M +$42.8M +10,402 New
BA
11
BlackRock Advisors
Delaware
$38.6M +$40.2M +9,756 New
BIT
12
BlackRock Institutional Trust
California
$38.2M +$39.7M +9,653 New
TSW
13
Thompson Siegel & Walmsley
Virginia
$27.8M +$29M +7,032 New
Goldman Sachs
14
Goldman Sachs
New York
$23.7M +$24.7M +5,996 New
FAM
15
Fred Alger Management
New York
$22.3M +$23.2M +5,642 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$21M +$21.8M +5,299 New
SI
17
Scout Investments
Missouri
$20.5M +$21.3M +5,176 New
ClearBridge Investments
18
ClearBridge Investments
New York
$20.3M +$21.1M +5,122 New
Northern Trust
19
Northern Trust
Illinois
$20M +$20.8M +5,043 New
JP Morgan Chase
20
JP Morgan Chase
New York
$19.1M +$19.8M +4,815 New
VOYA Investment Management
21
VOYA Investment Management
Georgia
$13.9M +$14.4M +3,504 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$13.6M +$14.2M +3,441 New
HM
23
HealthCor Management
New York
$13.3M +$13.8M +3,348 New
Deutsche Bank
24
Deutsche Bank
Germany
$12.4M +$12.9M +3,140 New
TA
25
Teachers Advisors
New York
$11.8M +$12.3M +2,982 New
1
2 3 4 5

ACOR Hedge Fund Activity: Q2 2013 in Review

148 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2013, worth a combined $1.32B.

Buyers outnumbered sellers: 148 funds opened new ACOR positions and 0 closed out — a net gain of 148 holders — while 0 added to existing stakes and 0 trimmed.

  • 148 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.32B of Acorda Therapeutics stock for Q2 2013.
  • 148 funds opened new Acorda Therapeutics positions in Q2 2013 and 0 closed out, a net change of +148 holders.

Based on aggregated 13F filings for Q2 2013.